Medicenna Therapeutics Corp. Weighted Average Share Price Share Options Granted2019
Medicenna Therapeutics Corp. (MDNAF) reported Weighted Average Share Price Share Options Granted2019 of 1.04 CAD/shares for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 · last filed 2023-06-27
| Period end | Weighted Average Share Price Share Options Granted2019 12 month |
|---|---|
| 2023-03-31 | 1.04 CAD/shares 20-F · filed 2023-06-27 |
| 2022-03-31 | 2.58 CAD/shares 20-F · filed 2023-06-27 |
| 2021-03-31 | 4.01 CAD/shares 20-F · filed 2023-06-27 |
| 2020-03-31 | 0.94 CAD/shares 20-F · filed 2022-06-22 |